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Heterochromatin Effects on the Frequency
and Duration of LCR-Mediated Gene Transcription
Eric Milot,* John Strouboulis,†‡ Tolleiv Trimborn,* suggesting that chromatin condensation can spread
from heterochromatin into regions of euchromatin (Wil-Mark Wijgerde,* Ernie de Boer,* An Langeveld,*
son et al., 1990). Stochastic heterochromatinization ofKian Tan-Un,§ Wilma Vergeer,*‖ Nikos Yannoutsos,*
juxtaposed euchromatic regions, which results in stablyFrank Grosveld,* and Peter Fraser*
inherited gene silencing in a clonal subpopulation of*Erasmus University
cells, is known as position-effect variegation (PEV; forMedical Genetics Center, Department of Cell Biology
review see Karpen, 1994). Evidence that PEV indeed3000 DR Rotterdam
results from heterochromatinization has come from ge-The Netherlands
netic studies of specific genes that encode proteins†National Institute for Medical Research
involved in heterochromatin formation and have beenDepartment of Gene Structure and Expression
shown to enhance or suppress these position effectsThe Ridgeway, Mill Hill
(Pirrotta, 1995; Orlando and Paro, 1995). Although theLondon NW7 1AA
dynamics of formation of the open and closed states ofUnited Kingdom
a locus are still obscure, it is clear that some genomic
elements and nuclear factors can influence the chroma-
tin configuration. In mammals, position effects that re-Summary
sult in the stable silencing of genes in a clonal subpopu-
lation of cells have also been observed (Elliot et al.,Locus control regions (LCRs) are responsible for ini-
1995; Festenstein et al., 1996).tiating and maintaining a stable tissue-specific open
Another type of position effect frequently observed inchromatin structure of a locus. In transgenic mice,
transgenic experiments is thought to be due to the ac-LCRs confer high level expression on linked genes
tion of regulatory elements at the site of integration. Thisindependent of position in the mouse genome. Here
can result in both positive and negative effects on thewe show that an incomplete LCR loses this property
transgene. Alternatively, the regulatory elements on the
when integrated into heterochromatic regions. Two transgenic construct may interact with a gene located
disruption mechanisms were observed. One is classi- at the site of integration and result in a lower level of
cal position-effect variegation, resulting in continuous transgene expression (see Milot et al., 1996). These non-
transcription in a clonal subpopulation of cells. The PEV effects result in a change in the level of expression
other is a novel mechanism resulting in intermittent in all of the expressing cells.
gene transcription in all cells. We conclude that only An increasing number of gene loci and gene clusters
a complete LCR fully overcomes heterochromatin si- have been shown to contain cis elements known as
lencing and that it controls the level of transcription locus control regions (LCRs), which are thought to be
by ensuring activity in all cells at all times rather than responsible for initiating or maintaining (or both) a cell
directly controlling the rate of transcription. type–specific open chromatin structure within a speci-
fied domain. The most thoroughly characterized LCR is
Introduction that of the human b-globin locus (Grosveld et al., 1993).
It consists of a series of five DNase I hypersensitive
Nuclear processes such as transcription, replication, site (HS) regions located upstream of the globin cluster
and recombination can be affected by chromatin struc- (Figure 1) each containing a number of binding sites for
ture (e.g., Pillus and Grunstein, 1995). The genome can ubiquitous and erythroid-specific DNA-binding factors.
Expression of b-globin transgenes without an LCR werebe roughly divided in two major chromatin states based
found to be low, variable, and dependent on the positionon cytological observation (Heintz, 1928; Eissenberg et
of integration in the host genome. Inclusion of LCR se-al., 1995). Euchromatin appears decondensed in in-
quences in b-globin transgene constructs led to reliable,terphase, whereas heterochromatin is highly condensed
high level, copy number–dependent expression irre-throughout the cell cycle. Euchromatic regions that con-
spective of position in the host genome (Grosveld et al.,tain most of the genes and unique sequences replicate
1987). This is in agreement with thestudy of patients withearly in S phase. Heterochromatin replicates late in S
deletions of the LCR. The globin genes in the otherwisephase (Holmquist, 1987) and contains middle and highly
normal locus were found to be insensitive to DNase I,repetitive sequences (John and Miklos, 1979). The
transcriptionally inactive (Kioussis et al., 1983; Forresterlargest regions of heterochromatin appear near the cen-
et al., 1990), and replicated late in S phase (Aladjem ettromeres and in the inactivated X chromosome. Studies
al., 1995).in Drosophila and yeast have shown that heterochroma-
The human b-globin LCR is thought to overcome posi-tin can have effects on juxtaposed euchromatic regions,
tion effects through a dominant positive activity rather
than through an insulator function (Schedl and Grosveld,
‡Present address: Laboratory of Molecular Embryology, National 1995). Recent studies demonstrate that the individual
Institute of Child Health and Human Development, National Insti- globin genes compete for LCR function and that the
tutes of Health, Bethesda, Maryland 20892.
LCR activates only one gene at a time (Wijgerde et al.,§Present address: School of Professional and Continuing Educa-
1995), probably through direct interaction between thetion, University of Hong Kong, Hong Kong.
LCR and the gene via DNA looping (Dillon et al., submit-‖ Present address: Department of Microbiology and Biochemistry,
University of Orange Free State, Bloemfontein 9300, South Africa. ted). These results suggested that the relative levels of
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Figure 1. Construction of 70 kb Globin Locus
LCR Deletion Mutants
The top line shows the 70 kb human globin
locus construct. The individual HS regions
of the LCR (59HS:1–5) are designated with
arrows and the globin genes with boxes. The
two cosmids (cos LCR e and cos ggdb; Strou-
boulis et al., 1992a, 1992b) used to create
the 70 kb construct are shown, as are the
positions of restriction sites used to make the
LCR plasmid subclones shown at the bottom.
Individual HS deletions were created in the
plasmids pHS:3–5 and pHS:1–2 using the re-
striction sites shown. Individual HS deletion
plasmids were incorporated into cos LCR e,
which was then linked to cos ggdb to create
the injection constructs as described by
Strouboulis et al. (1992b). Restriction sites
are as follows: N, NotI; M, MluI; C, ClaI; P,
Pm1I; S, SauI; A, ApaLI; Sn, SnaBI; Hp, HpaI;
Sp, SpeI.
gene expression in an active locus is (at least in part) blood and determined the level of mRNA by S1 nuclease
protection assays. Each sample was assayed with thedetermined by the duration of the interaction of the LCR
with each of the genes. In this paper, we report the same mixture of six probes for mouse, ey, bh1, b-major,
and human, e, g, and b (see Experimental Procedures).results obtained with transgenic mice containing the
entire globin locus with LCR HS deletions. The results S1 analyses are shown in Figure 2 for one transgenic
line from each construct as well as transgenic line 72,show that deletion of an individual HS from the LCR
leads to severely reduced expression of the globin which contains the full locus as a single integrated copy.
The intensity of each S1 protected band was correctedgenes in some mouse lines. In situ hybridization analysis
reveals that this loss of position independence is caused for probe-specific activity and copy number and is pre-
sented in Figure 3 as a percentage of endogenous globinby integration at or near the centromere, resulting in
pancellular and heterocellular position effects. We con- gene expression.
clude that the LCR must be complete to overcome het-
erochromatin silencing and that it does so by ensuring HS Deletions Affect Globin Gene Expression
The two HS:1 deletion lines (D1A, containing 1 copy ofthat the locus is active all of the time in all of the (red)
cells. the human locus, and D1B, containing 2 copies) show
widely varying levels of expression of the globin genes
per copy, indicating a loss of copy number dependence.Results
D1A globin gene expression is very low, ranging from
2%–10% per copy, whereas D1B expresses near normalGeneration of LCR Deletion Transgenic Mice
The preparation of 70 kb LCR deletion DNA fragments levels when compared with line 72 (Figures 2 and 3).
These results indicate that deletion of HS:1 may resultfor microinjection was carried out according to the cos-
mid linking method of Strouboulis et al. (1992a, 1992b). in expression that is sensitive to the position of integra-
tion in the mouse genome. D1B shows the level of ex-Four different locus constructs were produced with
small deletions of HS:1, HS:2, HS:3, or HS:4 (Figure 1). pression that would be expected on the basis of the
previous data obtained for HS:1. HS:1 itself is known toThe constructs were microinjected into the pronuclei of
fertilized mouse eggs to produce transgenic founder have very little if any transcriptional activity (Collis et al.,
1990; Fraser et al., 1990), and a patient with a deletionmice. Tail DNA from founder mice was analyzed on
Southern blots by probing with the entire 70 kb locus of HS:1 from the LCR has normal levels of b-globin
expression (Kulozik et al., 1991). More interesting is theconstruct (data not shown). Those founder mice, which
contained all of the EcoRI fragments characteristic of result obtained for the D1A line, which suggests that
59HS:1 is nevertheless an essential component of thethe entire locus, were selected for further breeding. F1
and F2 mice were similarly analyzed, and, in addition, LCR to provide position-independent expression of the
globin locus when taken out of the context of its normalend fragment, junction fragment, and internal probes
were used to verify the structure and estimate the copy chromosomal position (see below).
Based on previous data with the individual HS:2 (Tal-number. Transgenic line 72 was used as the control.
This line contains a single copy of the human globin bot et al., 1989, 1990; Curtin et al., 1989; Ryan et al.,
1989; Fraser et al., 1990, 1993; Morley et al., 1992) andlocus and expresses the human b-globin transgene at
a level similar to that of the endogenous mouse globin the deletion of the mouse b-major globin HS:2 by homol-
ogous recombination (Fiering et al., 1995), we expectedgenes (Strouboulis et al., 1992a). The mouse Thy-1 gene
was used as an internal loading control. Copy numbers that the deletion of HS:2 would result in a mild (20%–
30%) reduction in transcription of the genes in the locus.ranged from 1 to approximately 12 copies.
We prepared RNA from F2 transgenic 10.5 day whole However, the four lines containing the HS:2 deletion
construct (D2A, 8 copies; D2B, 3 copies; D2C, 1 copy;embryos, 12.5, 14.5, and 16.5 day fetal livers, and adult
Heterochromatin- and LCR-Mediated Transcription
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Figure 2. S1 Nuclease Protection Assays
S1 nuclease protection assays are shown for one transgenic line for each of the deletion constructs (D1A, 1 copy; D2A, 8 copies; D3A, 4
copies; D4A, 1 copy) used and line 72 (1 copy). RNA was prepared from transgenic 10 day whole embryos, 12, 14, and 16 day fetal livers,
and adult blood as described in Experimental Procedures. Two samples for each timepoint except adult blood are shown. All samples were
assayed with the same mixture of six radiolabeled probes for mouse ey, bH1, and b-major and human e, g, and b; the ratio of probe-specific
activities was 0.8:0.8:0.8:3.3:1:1, respectively. The position of the protected fragments for each probe are indicated.
and D2D, 1 copy) show varying levels of expression per the D2C line is detectable only in the adult, where human
b-globin expression is approximately 6% of the mousecopy, indicating a loss of copy number dependence and
hence position dependence (Figures 2 and 3). The most b-major globin. The other two D2 lines (D2A and D2B)
show a reduction in expression of all the human globinstriking examples of position sensitivity of the D2 lines
are D2C and D2D because they show a different effect genes at all stages. Hence, HS:2 also appears to be
crucial for the function of the LCR when integrated atfor different genes in the locus. D2D shows appreciable
levels of g-globin expression in the embryonic period, another position in the genome (see below).
The transgenic mice containing the HS:3 deletioncon-but very low levels of human b-globin in the fetal liver
and adult stages. In contrast, transgene expression in struct (D3A, 4 copies; D3B, 4 copies; D3C, 3 copies; and
Figure 3. Quantitation of S1 Assays for All Transgenic Lines
S1 assays were quantitated by phosphorimage analysis and corrected for probe-specific activity and copy number of the transgenic line.
Copy numbers are indicated in parentheses. The values shown are the per copy levels of expression of the human genes as a ratio of the
endogenous mouse globin genes (human gene/copy number/[ey 1 bH1 1 b-major]).
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D3D, 12 copies) were expected to show at least the noncentromeric locations with the exception of line 2
(Strouboulis et al., 1992a), which is integrated close tosame or greater reduction in expression, in particular of
the embryonic and fetal genes (Fraser et al., 1990, 1993; a centromere (Figures 4A and 4B). This line, which con-
tains a single copy of the 70 kb locus, expresses thePhilipsen et al., 1990, 1993; Hug et al., 1996). Indeed,
the results show a general reduction in expression of human globin genes normally.
all the human genes, but also a lack of copy number
dependence (Figures 2 and 3). D3C in particular is ex- In Situ mRNA Analysis
pressing at less than half the level per copy of the other In view of the well-characterized PEV observed in Dro-
D3 lines. This suggests that deletion of HS:3 from the sophila and yeast, we next addressed the question of
LCR also causes susceptibility to position effects (see whether the position effect we observed in the LCR
below). deletion lines was due to a reduction of the number of
Three lines contain the HS:4 deletion construct (D4A, cells that express the transgene (as expected for PEV)
D4B, and D4C) with copy numbers of 1, 2, and 3, respec- or whether the expression level in each cell had been
tively. These lines appear to express the globin genes affected. To this end, in situ hybridization and indirect
in a position-independent and copy number–dependent immunofluorescence were performed on disrupted fetal
manner, as the level of expression per copy is similar liver cells from the four position-effect lines as well as on
to line 72. other LCR-deletionand complete LCRlines with specific
probes for human and mouse b-globin mRNA. The re-
sults show that in all lines tested, with the exception ofChromosomal Position of Transgenes
D2B and D2C (Figure 5), the human transgene is ex-The results of the S1 analysis showed that the LCR
pressed in all erythroid cells, since every cell that con-deletion transgenic lines express the human globin
tains mouse b-major globin mRNA also contains humangenes at lower levels than expected. In addition, the
b-globin mRNA (Figure 5). In the two position-effect LCRlevels of expression do not correlate with the number
deletion lines, D2B and D2C, the transgene shows varie-of copies integrated in the mouse genome. In particular,
gated expression patterns, as human b-globin mRNA istransgenic lines D1A, D2B, D2C, D2D, and D3C show
present in only 25% and 4% of the cells, respectively,extremely low levels of expression per copy when com-
of every erythroid fetal liver examined. In situ hybridiza-pared with line 72 or the other deletion lines. Studies in
tion of individual colonies from methyl cellulose culturesDrosophila and yeast have shown that chromosomal
of line D2B fetal liver cells indicates that expressionposition can influence gene expression. To determine
status is clonally inherited (data not shown). We con-whether reduced gene expression in these mice can be
clude that the reduced level of transgene expressioncorrelated with chromosomal position, we performed
seen in these two lines results from clonally inheritedfluorescence in situ hybridization (FISH) analysis on
PEV caused by centromeric heterochromatinization.metaphase chromosomes from ten LCR deletion trans-
genic lines (lines D1B and D2D were lost before FISH
analysis; D3D was not done). All four of the very low DNase I and Restriction Enzyme Sensitivity
Since the FISH and in situ mRNA analyses revealedexpressing lines (D1A, D2B, D2C, and D3C; Figure 3)
were integrated at or near the centromere (Figure 4A). that D2B and D2C were in heterochromatic regions and
subject to PEV, whereas all other lines expressed theThis suggests that pericentromeric integration of an in-
complete LCR construct results in severely reduced genes in all erythroid cells, it could be expected that
a difference in DNase I sensitivity would be observedgene expression. Such a position effect may be caused
by heterochromatin spreading as is thought to occur in between the different lines. Expression of the locus in
erythroid cells normally correlates with the presence ofPEV. Since FISH on metaphase chromosomes is a crude
method for determining the precise chromosomal loca- DNase I HS in the LCR and an HS in the promoter of
the b-globin gene (Tuan et al., 1985; Forrester et al.,tion of a transgene, we refined these results by using a
second probe for the mouse a-satellite repeat (Figure 1987; Grosveld et al., 1987). We therefore tested for the
presence of the erythroid-specific HS:5 (Zafarana et al.,4B), which is located primarily in centromeres. All four
lines D1A, D2B, D2C, and D3C are integrated very close 1995) in the LCR (present in all constructs) and the HS
found in the promoter of the b-globin gene using theto or contacting the a-satellite DNA, whereas the next
closest integrant (D2A) is clearly separate (Figure 4B). mouse b-major gene promoter as a control (Table 1).
Only lines D2B and D2C (the PEV lines) showed severelyThe accumulated data from a number of laboratories
present a large number of complete LCR transgenics reduced or an absence of sensitivity, whereas all other
lines, including D1A and D3C (severe PE), showed thethat express their linked transgenes in a copy number–
dependent, position-independent manner, suggesting LCR and promoter sites. We also assayed restriction
enzyme sensitivity using ApaLI digestion in isolated nu-that the full LCR is able to overcome centromeric posi-
tion effects. This would not be expected on a statistical clei from lines D1A and D2B and line 72. ApaLI cuts at
150 in exon 1 of the human b-globin gene. As expectedbasis if centromeric silencing of the complete LCR were
to occur. However, the chromosomal position of full LCR from the DNase I results, ApaLI sensitivity in line 72 and
D1A appeared similar, with approximately 60% di-transgenic lines had not previously been reported, and
hence we analyzed the chromosomal position of the gested, whereas the PEV line D2B showed a reduction
in ApaLI sensitivity, with less than 20% digested (dataeight full LCR transgenic lines available in our laboratory
(Strouboulis et al., 1992a; Dillon et al., submitted; J. not shown). These results suggest that the position ef-
fect observed in D2B and D2C is indeed caused by aGribnau et al., unpublished data). All were integrated in
Heterochromatin- and LCR-Mediated Transcription
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Figure 4. FISH Analysis of Transgenic Lines
(A) Left panels (red) show the human b-globin
transgene locus detected by in situ hybridiza-
tion of metaphase chromosomes of adult
bone marrow cells with the complete insert
as a probe (see Experimental Procedures).
Right panels show DAPI staining (blue); cen-
tromeres correspond to the light blue areas.
Transgenic line numbers are indicated on top
of each sample.
(B) Double-label FISH of bone marrow meta-
phase chromosomes from the pericentrom-
eric lines using probes for the human globin
locus (green) and mouse a-satellite DNA
(red).
closed chromatin conformation such as seen in hetero- cells (Wijgerde et al., 1995). Lines D1A and D3C have
significantly lower percentages (25% and 75%, respec-chromatin, but they do not give an indication about the
nature of the position effect observed in D1A and D3C. tively) of erythroid cells with human b-globin primary
transcript signals (Figure 6; Table 2). The fact that all
erythroid cells in these lines have human b-globin mRNAIn Situ Primary Transcript Analysis
Similar to the full LCR line 72, the two low expressing in their cytoplasm (Figure 5) demonstrates that the
transgenes are active in each cell. The low percentagepericentromeric lines D1A and D3C express the human
transgene in all erythroid cells. We decided to investi- of transcriptionally active cells indicates that each
transgene is transcribed for only a fraction of the normalgate the reduced expression levels of these two lines
further by comparing the transcriptional status from sev- time.
As expected, the PEV line D2B had human primaryeral lines. We performed primary transcript in situ hy-
bridizations with gene-specific intron probes for human transcript signals in only 25% of erythroid fetal liver cells
(Table 2), consistent with the percentage of erythroidb-globin and mouse b-major globin in 13.5 day fetal liver
Cell
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Table 1. DNase I Sensitivity
Transgenic Human LCR Human b-Globin Mouse b-Major
Line HS:5 Promoter Globin Promoter
Line 72a 1 1 1
D1Ab 1 1 1
D2A 1 1 1
D2Bb, c 2 2 1
D2Cb, c 2 2 1
D3B 1 1 1
D3Cb 1 1 1
D4B 1 1 1
D4C 1 1 1
The DNase I hypersensitivity analysis was carried out on isolated
nuclei from 13.5 day fetal liver cells. The presence or absence of
LCR HS:5 or the HS in the human or mouse b-globin promoters is
indicated by a plus or minus sign. The left column shows the
transgenic mouse line number. The probes used are described in
Experimental Procedures.
a Complete LCR.
b Pericentromeric location.
c PEV lines.
D2B and the timing effect line D1A to homozygosity.
These two lines were chosen because the percentage
of erythroid cells that had human globin transcription
foci were the same in both lines (25%). If transgene
activation is random, as is expected for PEV (Elliot et
al., 1995), and the individual loci in a homozygous cell
are stochastically activated or silenced, then the number
of transcriptionally positive erythroid cells should in-
crease from 25% to 44%. Most of these cells should
have only one active locus and approximately 6% should
Figure 5. mRNA In Situ Hybridization
have both transgene loci active. Transcription was ana-
Left panels (green) show the in situ hybridization of 13.5 day fetal
lyzed via primary transcript in situ hybridizations forliver cells using a mouse b-major mRNA digoxigenin-labeled oligo-
human and mouse b-globin. As expected for the PEVnucleotide from the third exon as the probe (Wijgerde et al., 1995).
line (D2B), the percentage of transgene-expressing cellsMiddle panels show detection in the same cells of a deoxyribonucle-
oprotein (DNP)-labeled human b-globin third exon oligonucleotide increased significantly in the homozygous fetal liver,
probe (Wijgerde et al., 1995). Right panels show the overlay of the from 25%to 43%. Most of these cells (74%) had only one
two images. Transgenic mouse line numbers are shown on the left. chromosome actively transcribing the human genes. A
quarter of these cells (26%) showed active transcription
originating from both transgene chromosomes. Thesecells that contained human b-globin mRNA (Figure 5).
results are what would be expected from a stochasticThe full LCR control line 72 had b gene transcription
activation of the globin transgene. In contrast, the per-signals in 87% of the erythroid cells as expected (10%–
centage of transcription-positive cells in the D1A line15% of loci transcribe the g- or d-globin genes at this
did not increase significantly in the homozygotes (25%–stage [M. W. et al., unpublished data]). The highly ex-
31%), and surprisingly 80% of these cells show activepressing LCR deletion lines (D4A, D4B, and D4C) had
transcription from both transgene loci. This result is thepositive transgene transcription signals in a high per-
complete opposite of the PEV result. Therefore, locuscentage of erythroid cells (Table 2). In the single-copy
activation in D1A appears to be a cellular timing phe-line D4A, the percentage of cells positive for b-globin
nomenon, since both chromosomes are activated simul-transcription is similar to the single-copy line 72. The
taneously in a single cell and not stochastically at thepercentages approach 100% in the multicopy D4 lines
level of the individual locus as in PEV. These results(D4B and D4C) as expected,suggesting that the b-globin
suggest that differentiation stage or cell cycle phaseloci in these lines are continually active. Of potential
may be important in controlling heterochromatin-medi-significance is the fact that the multicopy lines D2A and
ated silencing of the D1A transgene.D3B do not approach 100%, as would be expected if
they were transcribing normally as in the D4 lines. This
result suggests that they too may be transcribed for Discussion
only part of the time.
We have analyzed the developmental expression pat-
tern of the 70 kb human b-globin locus constructs inStochastic versus Timing Phenomenon
In an attempt to characterize further the novel position transgenic mice after deletion of individual HS from the
LCR. Of 13 transgenic lines presented, at least 5 exhibiteffect observed in D1A and D3C, we bred the PEV line
Heterochromatin- and LCR-Mediated Transcription
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Figure 6. Primary Transcript In Situ Hybrid-
ization Analysis
In situ hybridization with gene-specific intron
probes as described by Wijgerde et al. (1995).
Red foci represent mouse b-major globin pri-
mary transcript (DNP labeled); green foci rep-
resent human b-globin primary transcript (di-
goxigenin). Transgenic mouse line numbers
are indicated at the top.
extremely low levels of expression per copy. This dem- the levels of mRNA, DNase sensitivity, and restriction
enzyme sensitivity have been severely decreased in theonstrates that deletion of a single HS can result in loss of
position independence and copy number dependence, total population of cells. The second type of position
effect exhibits low levels of transgene expression in allwhich are the major distinguishing features in the func-
tional definition of an LCR (Grosveld et al., 1987), and erythroid cells as evidenced by the S1 and mRNA in situ
analysis. However, this low level of expression appearssuggests that expression of these transgenes is being
influenced by the chromatin environment of the integra- not to be caused by a general decrease in the rate of
transcription of the individual genes. Rather, precursortion locus. The exceptions to this loss of function are
the HS:4 deletion lines, which appear to show copy RNA analysis reveals that only a fraction of the erythroid
cells are transcribing the transgene at any moment, sug-number–dependent and position-independent expres-
sion. However, with only three lines, it is possible that gesting that low expression in these lines is caused by
a decrease in the amount of time that the transgenethe transgenes in these mice have fortuitously landed
is transcriptionally active in a particular cell. DNase Iin favorable chromosomal environments, and as a result
hypersensitivity and restriction enzyme sensitivity arethe expression patterns observed appear position in-
maintained in these lines, suggesting that this positionsensitive (Figure 4). However, others have shown that
effect is caused by a chromatin conformation that differsdeletion of HS:4 from the locus can also result in loss
from PEV. This result also suggests that DNase I hyper-of function (Bungert et al., 1995).
sensitivity is not proportionally linked to transcription.FISH analysis revealed that the transgenes in the low-
Analysis of homozygous animals confirms that tran-est expressing lines were integrated at or near the
scriptional activation is a cell-timing phenomenon andcentromere in each case. This type of pericentromeric
is not stochastic as in PEV. This presents two intriguinglocalization of genes has been shown to lead to hetero-
possibilities. First, we may be observing a window ofchromatin-induced silencing in Drosophila and yeast
reorganization of the genome during thecell cycle.Thus,and, more recently, in mammals in the case of the CD2
the transgenes may be switching on briefly after disrup-LCR (Festenstein et al., 1996). We show through in situ
tion of higher order structure and then off again as het-analyses that reduced expression of pericentromeric
erochromatin spreads into the locus, or vice versa. Sec-transgenes can be accomplished by at least two func-
ond, the transgene locus may be silenced prior totionally distinct mechanisms. The first is PEV, which
terminal differentiation of the red cells, which could ac-results in a clonal subpopulation of erythroid cells that
count for the difference in transcriptional frequency ob-express the human globin genes. As a consequence,
served between the transgene and endogenous loci.
The cell-timing effect may also be seen to a lesser
Table 2. Percentage of Erythroid Cells Positive for Human extent in the noncentromeric LCR deletion transgenes
Globin Transcription Foci (D2A [8 copies] and D3B [4 copies]). For example, tran-
Transgenic Copy Human b Foci scription in situ analysis of line D3B shows that even
Line Number Mouse b Foci 3 100 though this line contains 4 copies of the transgenic lo-
cus, the percentage of erythroid cells that are transcrip-Line 72a 1 87
tionally positive for human b-globin is slightly lower thanD1Ab 1 25
D2A 8 89 the single-copy full LCR line 72. This suggests that the
D2Bb, c 3 25 LCR of each locus in these multicopy deletion lines
D3B 4 83 spends a considerable amount of time uncoupled from
D3Cb 3 75
the genes. The length of time that the LCR remains
D4A 1 86
uncoupled appears to be exaggerated in the pericen-D4B 2 97
tromeric lines, which suggests that heterochromatin for-D4C 3 95
mation is somehow interfering with LCR activation, lead-
Transcription foci were detected for mouse and human b-globin
ing to the severe reduction in expression. Clearly thisgenes in heterozygous 13.5 day fetal liver cells as in Figure 6. The
process is very different from PEV.percentage of erythroid cells (i.e., cells positive for b-major tran-
The results to date have shown that the individual HSscription) that show transcription foci for the human b-globin gene
are shown for various transgenic lines. of the LCR appear additive, as most or all were neces-
a Complete LCR. sary for full expression (see Grosveld et al., 1993). The
b Pericentromeric location. data presented here suggest that this additive effect is
c PEV line.
not accomplished through an increase in the density of
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polymerases on an individual gene, but (at least in part) expression by determining the frequency and the dura-
tion of transcription periods, rather than only controllingthrough an increase in the stability of the LCR–gene
complex leading to increased frequency and duration the rate of transcription.
of transcription periods. These results may seem to be
in contradiction with the recently published analysis of Experimental Procedures
deletions of the mouse b-major globin HS:2 and HS:3
Construction of Human b-Globin Locus LCRin their native positions in the mouse genome (Fiering
Deletion Constructset al., 1995; Hug et al., 1996), both of which result in a
The human b-globin LCR was subcloned in two parts in pBR322.30% reduction in the expression of the mouse adult b
HS:4 was removed from the plasmid containing the 59 half of the
genes only. Those experiments cannotmeasure position LCR by deletion of an 875 bp Pm1I fragment that included the entire
independence, since the mouse b-globin locus is main- HS:4 core fragment as definedby Pruzina et al. (1991) to give plasmid
tained at its original position in the genome. Our obser- DHS:4. HS:3 was deleted by removal of a 1.38 kb SauI fragment
that includes the HS:3 core as defined by Philipsen et al. (1990) tovations suggest that the reduced expression seen in
give plasmid DHS:3. The HS:2 core (Talbot et al., 1990) was removedthose knockout lines may be caused by a decrease
by deletion of a 742 bp ApaLI–SnaBI fragment to give plasmid DHS:2.in the stability of the LCR–gene complex leading to a
The DHS:1 plasmid was created by deletion of a 1.7 kb HpaI–SpeI
reduction in frequency or duration of transcription. In fragment that includes 919 bp from the 1.02 kb HS:1 fragment used
this respect, it is worth noting that the individual dele- by Talbot et al. (1989). The four 70 kb LCR deletion constructs were
tions have essentially the same effect and that the effect prepared by incorporating the deletion plasmids into cosmid (cos)
LCR e, which was linked to the 39 cosmid (cos ggdb) and purifiedis greatest on the most distal genes.
for microinjection as described by Strouboulis et al. (1992).The constructs described here are subject to an inher-
ent selection since the constructs are capable of very
Transgenic Micehigh levels of expression. As a result, the integration
Purified fragments were microinjected into the pronuclei of FVBof multiple copies in areas of the genome that permit
fertilized mouse eggs and transferred into the oviducts of pseudo-
expression is lethal (Hanscombe et al., 1989).Thus, there pregnant (CAB 3 C57B1) F1 female mice. Transgenic founders were
is a bias toward survival of transgenic lines in which identified via Southern blotting of tail DNA. Transgenic DNA was
integration occurs in areas of the genome that reduce probed with the 70 kb injection fragment on Southern blots. Those
that contained all the EcoRI fragments characteristic of the entirethe level of expression. This is supported by the inherent
locus wereselected for further breeding and analysis. Copy numbersdifficulty in obtaining mouse lines that contain intact
were determined by quantitation of Southern blots via phosphorim-multiple copies of the complete locus (see also Strou-
age analysis. End fragment, junction fragment, and internal probes
boulis et al., 1992a; Dillon et al., submitted) and may were used to determine the copy numbers and verify the structure
explain why a higher than expected number of our lines of the transgenes.
have insertions in or near the centromere.
The results have important implications for the pro- Preparation of RNA and S1 Nuclease Protection Assays
posed mechanisms of LCR activation of gene expres- RNA was prepared from whole, frozen, transgenic 10.5 day embryos
and fetal livers from 12.5, 14.5, and 16.5 day and adult blood andsion. We have previously proposed that the different HS
subjected to S1 nuclease protection assays as previously describedregions of the LCR may act together as a single func-
(Fraser et al., 1990). The probes used were those described bytional unit that interacts with a single gene in the locus
Lindenbaum and Grosveld (1990) with the exception of the human
at any given time. This may be through formation of a g-globin probe. The human g-globin probe was a 315 bp AvaII frag-
holocomplex in which the individual HS must first inter- ment taken from a plasmid containing the human A g-globin cDNA
act among themselves to form a larger complex, which ligated to the human A g-globin 59 flanking region. Human g-globin
RNA protects a 165 bp fragment of this probe from S1 nucleasebecomes the limiting element in gene competition.
cleavage. Protected bands on the S1 gels were quantitated viaClearly, deletion of one of the HS from the LCR results
phosphorimage analysis (Molecular Dynamics).in position sensitivity and loss of copy number depen-
dence, which suggests that the deletions may disrupt
DNA FISH Analysisthe normal interactions between the HS and the genes
Extracted bone marrows were cultivated for 24 hr in RPMI 1640
or formation of a holocomplex. This disruption appears medium (GIBCO BRL). Chromosome preparations were made ac-
to prevent the normal dominant positive effect of the cording to standard procedures. FISH was carried out as described
by Mulder et al. (1995). The probes used were the linked humanLCR from overcoming negative effects that are thought
b-globin locus (70 kb fragment) or a mouse minor satellite dimerto occur in heterochromatic regions of the genome.
(gift of A. Mitchell). The probes were labeled with biotin and digoxy-Hence, we suggest that initiation of transcription from
genin and immunochemically detected with fluorescein or Texasa competent gene in the “open” chromatin domain of
red. The DNA was counterstained with DAPI.
the globin locus originates only through direct complex
formation with the LCR and maintenance of that tran-
HS Assay
scription requires continued association (see also Wij- Ten transgenic fetal livers (13.5 days) for each line were treated
gerde et al., 1995). Deletions that decrease the stability as described by Forrester et al. (1990). Suspension of nuclei was
of LCR–gene interactions decrease the frequency or performed by 20 strokes of a Dounce pestle (type B) and 100 ml
aliquots were digested for 3 min at 378C with an increasing amountshorten the duration (or both) of such associations,
of DNase I. Reactions were stopped and treated with proteinase Kthereby reducing the transcriptional output from a given
and extracted with phenol–chlorophorm. After ethanol precipitation,gene by decreasing the period of activity. This effect is
the pellet was resuspended in 100 ml of water. We then digested
most obvious in heterochromatic regions of the genome 30 ml with EcoRI, followed by Southern blot analysis. Hybridizations
where the LCR spends a significant amount of time were performed with the EcoRI fragment covering 59HS:5, BamHI–
uncoupled (i.e., not activating any globin gene). There- EcoRI human bIVS II, or with an XbaI–Sau3A fragment covering the
mouse b-major promoter.fore, the complete LCR determines the level of gene
Heterochromatin- and LCR-Mediated Transcription
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mRNA and Primary Transcript In Situ Hybridization hypersensitive site of the human b globin locus control region con-
fers a different developmental pattern of expression to the globinPrimary transcript and mRNA in situ hybridizations to detect tran-
scriptional activity and expression of the human and mouse b-globin genes. Genes Dev. 7, 106–113.
genes in fetal liver cells were performed as described by Wijgerde Grosveld, F., Blom van Assendelft, G., Greaves, D.R., and Kollias,
et al. (1995). Quantitation of transcription signals was done by count- G. (1987). Position-independent, high level expression of the human
ing at least 1000 cells from each line with an epifluorescence micro- b-globin gene in transgenic mice. Cell 51, 975–985.
scope. The figures presented were created with a laser scanning
Grosveld, F., Dillon, N., and Higgs, D. (1993). The regulation of human
confocal microscope.
globin gene expression. Baillieres Clin. Haematol. 6, 31–66.
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